dactinomycin has been researched along with amyloid beta-peptides in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bembinster, LA; Bennett, DA; Cole, SL; De Strooper, B; Eimer, WA; Haass, C; Hébert, SS; Hitt, B; Lammich, S; Lichtenthaler, SF; Maus, E; O'Connor, T; Sadleir, KR; Vassar, R; Velliquette, RA; Zhao, J | 1 |
1 other study(ies) available for dactinomycin and amyloid beta-peptides
| Article | Year |
|---|---|
Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.
Topics: Age Factors; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Antimetabolites; Aspartic Acid Endopeptidases; Cells, Cultured; Cerebral Cortex; Convulsants; Dactinomycin; Deoxyglucose; Disease Models, Animal; eIF-2 Kinase; Embryo, Mammalian; Enzyme Activation; Gene Expression Regulation; Glucose; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Nitro Compounds; Peptide Fragments; Phosphorylation; Plaque, Amyloid; Propionates; Protein Synthesis Inhibitors; Time Factors; Transcription Factors; Transfection | 2008 |